SEC Form 4 research
| Issuer | AbCellera Biologics Inc. |
|---|---|
| Tickers | ABCL |
| Reporting owners | 21 |
| Officers and directors | 9 |
| Last public filing | 2026-08-25 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-24 | 2026-08-24 | Hayden Michael R | P | 53,613 | $10.64 | Not reported |
| 2026-08-18 | 2026-08-18 | Montalbano John S. | P | 10,000 | $11.03 | Not reported |
| 2026-08-14 | 2026-08-14 | Booth Andrew | P | 37,200 | $10.32 | Not reported |
| 2026-08-14 | 2026-08-12 | Hayden Michael R | P | 46,387 | $10.37 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.